Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caca

Showing results (151-160 of 255) with videos related to

Pageof 26
Sort By:
Zeitschrift Fur Gastroenterologie|May 5, 2005
[Is 18F-FDG-PET suitable for therapy monitoring after palliative photodynamic therapy of non-resectable hilar cholangiocarcinoma?]D Müller, M Wiedmann, R Kluge, et al.
Advances in Experimental Medicine and Biology|December 22, 1999
Pyoderma gangrenosum successfully treated with cyclosporin AM T V'lckova-Laskoska, D S Laskoski, N G Caca-Biljanovska, et al.
Gastrointestinal Endoscopy|July 2, 2004
Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II studyMarcus Wiedmann, Frieder Berr, Ingolf Schiefke, et al.
Cutaneous and Ocular Toxicology|May 23, 2013
Intraoperative corneal thickness measurements during corneal collagen cross-linking with isotonic riboflavin solution without dextran in corneal ectasiaYasin Cınar, Abdullah Kürşat Cingü, Alparslan Sahin, et al.
Zeitschrift Fur Gastroenterologie|September 18, 2018
Doppler ultrasound surveillance of TIPS-patency in the era of covered stents - retrospective analysis of a large single-center cohortChristoph Klinger, Bettina Riecken, Johannes Müller, et al.
Surgical Endoscopy|June 13, 2019
Endoscopic full-thickness resection of gastric subepithelial tumors with the gFTRD-system: a prospective pilot study (RESET trial)Benjamin Meier, Arthur Schmidt, Nicolas Glaser, et al.
Journal of Chemotherapy (Florence, Italy)|March 18, 2008
Bendamustine--a new approach to the treatment of advanced hepatocellular carcinoma?M Wiedmann, J Zeh, K Schoppmeyer, et al.
Anti-Cancer Drugs|August 24, 2006
Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinibMarcus Wiedmann, Jürgen Feisthammel, Thilo Blüthner, et al.
Gastroenterology|January 31, 2003
Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell linesDominik Huster, Michael Hoppert, Svetlana Lutsenko, et al.
International Journal of Cancer|January 22, 2002
Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell linesKarel Caca, Jürgen Feisthammel, Karen Klee, et al.
Pageof 26

Showing results (151-160 of 255) with videos related to

Sort By:
Pageof 26
Zeitschrift Fur Gastroenterologie|May 5, 2005
[Is 18F-FDG-PET suitable for therapy monitoring after palliative photodynamic therapy of non-resectable hilar cholangiocarcinoma?]D Müller, M Wiedmann, R Kluge, et al.
Advances in Experimental Medicine and Biology|December 22, 1999
Pyoderma gangrenosum successfully treated with cyclosporin AM T V'lckova-Laskoska, D S Laskoski, N G Caca-Biljanovska, et al.
Gastrointestinal Endoscopy|July 2, 2004
Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II studyMarcus Wiedmann, Frieder Berr, Ingolf Schiefke, et al.
Cutaneous and Ocular Toxicology|May 23, 2013
Intraoperative corneal thickness measurements during corneal collagen cross-linking with isotonic riboflavin solution without dextran in corneal ectasiaYasin Cınar, Abdullah Kürşat Cingü, Alparslan Sahin, et al.
Zeitschrift Fur Gastroenterologie|September 18, 2018
Doppler ultrasound surveillance of TIPS-patency in the era of covered stents - retrospective analysis of a large single-center cohortChristoph Klinger, Bettina Riecken, Johannes Müller, et al.
Surgical Endoscopy|June 13, 2019
Endoscopic full-thickness resection of gastric subepithelial tumors with the gFTRD-system: a prospective pilot study (RESET trial)Benjamin Meier, Arthur Schmidt, Nicolas Glaser, et al.
Journal of Chemotherapy (Florence, Italy)|March 18, 2008
Bendamustine--a new approach to the treatment of advanced hepatocellular carcinoma?M Wiedmann, J Zeh, K Schoppmeyer, et al.
Anti-Cancer Drugs|August 24, 2006
Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinibMarcus Wiedmann, Jürgen Feisthammel, Thilo Blüthner, et al.
Gastroenterology|January 31, 2003
Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell linesDominik Huster, Michael Hoppert, Svetlana Lutsenko, et al.
International Journal of Cancer|January 22, 2002
Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell linesKarel Caca, Jürgen Feisthammel, Karen Klee, et al.
Pageof 26